Does a detectable HCV RNA at the end of DAA therapy herald treatment failure?
Zarębska-Michaluk D, Flisiak R, Janczewska E, Berak H, Mazur W, Janocha-Litwin J, Krygier R, Dobracka B, Jaroszewicz J, Parfieniuk-Kowerda A, Dobrowolska K, Rzymski P.
Zarębska-Michaluk D, et al. Among authors: dobrowolska k.
Antiviral Res. 2023 Dec;220:105742. doi: 10.1016/j.antiviral.2023.105742. Epub 2023 Nov 7.
Antiviral Res. 2023.
PMID: 37944825
Free article.